T3SLA Innovations Incorporated

12/30/2020

Last night, LifeWatch project leads delivered an online presentation for the IEEE New Orleans Section titled “Biomedical Solutions to Mortality During a Surging National Opioid Epidemic,” outlining the LifeWatch development process and answering questions for engineers from a range of backgrounds. While these meetings are normally in-person events hosted by local venues, due to the COVID-19 pandemic, this and other IEEE events have been hosted via Zoom.

We plan to make the contents of the presentation available in the near future for anyone interested in learning about the work.

Riley Mayes is an electrical engineer who works with plasma instrumentation to provide data measurements of the earth’s ionosphere. The ionosphere helps to support all life on Earth. Since it is important to study and understand the underlying principles of the earths’ atmosphere, it is also equ...

10/03/2020

T3SLA Innovations is now accepting applications for participants in the LifeWatch Study and Trials. If you are 18 years of age or older and have struggled with op**te addiction in the past or present, you may sign-up at the website using the link in the post below and help develop a more reliable product to save lives in the near future!

Here you can sign up to participate in Phase I for the LifeWatch Study and Trials! We welcome both those in recovery, as well as active addiction.

09/25/2020

After our latest price assessment for individual parts, we have determined that we can make an even more basic version of LifeWatch, with an awesome cost coming in at only around $25-35/unit (not including Naloxone). Only two adjustments made this possible: 1) bulk pricing saves us about 40% when buying 1,000 parts at a time versus just one; 2) removing the touchscreen interface drastically cuts costs without sacrificing reliability, to where our parts cost would sit around $20/unit (unassembled). It’s still preliminary at this point, because we have to make sure the selected peripheral still meets our requirements, but we feel pretty confident in that respect.

While we still plan to run our trials with the touchscreen model already designed, it is reassuring to know that we could produce a product that saves lives at a price nearly everyone could afford, in the event they either don’t have insurance, or don’t want to go through that process. We could expect such a basic model to be priced at under $50, and provide the same level of monitoring and response as other models.